Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second largest pharmaceutical company in Japan. It achieved JPY 1,148.2 billion in revenue in 2013. The company owns the American biotechnology company Plexxikon, the ... Daiichi Sankyo, Inc. (DSI) began operating in the U.S. in 2006.
Daiichi Sankyo, About Us, Company Profile, Company information. ... Daiichi Sankyo, Inc. (United States). Business .... Daiichi Sankyo (China) Holdings Co., Ltd.
Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.
May 30, 2018 ... Surviving company. Extinct company. Extinct company. 1. Company name. Luitpold, Inc. American Regent, Inc. PharmaForce, Inc. 2.
U.S. Corporate Headquarters. Daiichi Sankyo, Inc. 211 Mt. Airy Road Basking Ridge, NJ 07920-2311. Phone: 908-992-6400. Fax: 973-944-2645 ...
As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, ... Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to ...
About Daiichi Sankyo, Inc. Products · Patient Assistance Program · Research & Development · News Releases · Responsibility · Contact Us · Careers.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo, Co., LTD and a member of the Daiichi Sankyo Group.
Daiichi Sankyo, Inc. is the U.S. headquarters of Tokyo-based Daiichi Sankyo, Co. , Ltd. and a member of the Daiichi Sankyo Group, which spans 20 countries.